Cargando…
Soluble CD73 in Critically Ill Septic Patients – Data from the Prospective FINNAKI Study
BACKGROUND: CD73 dephosphorylates adenosine monophosphate to adenosine that is an anti-inflammatory molecule inhibiting immune activation and vascular leakage. Therefore, CD73 could be an interesting mediator both in sepsis and acute kidney injury (AKI). We aimed to explore the soluble CD73 (sCD73)...
Autores principales: | Vaara, Suvi T., Hollmén, Maija, Korhonen, Anna-Maija, Maksimow, Mikael, Ala-Kokko, Tero, Salmi, Marko, Jalkanen, Sirpa, Pettilä, Ville |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061395/ https://www.ncbi.nlm.nih.gov/pubmed/27732656 http://dx.doi.org/10.1371/journal.pone.0164420 |
Ejemplares similares
-
Variation in the use of renal replacement therapy in patients with septic shock: a substudy of the prospective multicenter observational FINNAKI study
por: Poukkanen, Meri, et al.
Publicado: (2014) -
Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
por: Mildh, Henriikka, et al.
Publicado: (2016) -
Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung
por: Jalkanen, Juho, et al.
Publicado: (2020) -
Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: data from the FINNAKI observational study
por: Inkinen, Nina, et al.
Publicado: (2019) -
Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study
por: Poukkanen, Meri, et al.
Publicado: (2013)